Trial Profile
Examination of the medication effect using duloxetine in the patients with burning mouth syndrome and glossodynia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2019
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Burning mouth syndrome
- Focus Therapeutic Use
- 08 Aug 2019 Status changed from not yet recruiting to completed.
- 14 Jul 2014 New trial record